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Fluorescence microscopyTime-lapse ﬂuorescence microscopy of single, growing Bacillus subtilis cells with 2–12 s time resolution re-
veals the mechanisms of antimicrobial peptide (AMP) action on a Gram-positive species with unprecedented
detail. For the human cathelicidin LL-37 attacking B. subtilis, the symptoms of antimicrobial stress differ dra-
matically depending on the bulk AMP concentration. At 2 μM LL-37, the mean single-cell growth rate de-
creases, but membrane permeabilization does not occur. At 4 μM LL-37, cells abruptly shrink in size at the
same time that Sytox Green enters the cytoplasm and stains the nucleoids. We interpret the shrinkage
event as loss of turgor pressure (and presumably the membrane potential) due to permeabilization of the
membrane. Movies of Sytox Green staining at 0.5 frame/s show that nucleoid staining is initially local,
more consistent with pore formation than with global permeabilization models. In a novel “growth recovery”
assay, cells are incubated with LL-37 for a variable period and then rinsed with fresh growth medium lacking
LL-37. The growth rate attenuation observed at 2 μM LL-37 is a recoverable symptom, while the abrupt cell
shrinkage observed at 4 μM LL-37 is not.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are components of the innate im-
mune system of many organisms, including insects, mammals, and
amphibians [1,2]. AMPs function as both antimicrobial agents and
modulators of the immune system. While there is considerable diver-
sity in the sequence and structure of these peptides, most have a net
positive charge, a mixture of cationic and hydrophobic residues, and
an amphipathic structure when bound to model lipid bilayers. The
net positive charge allows the peptides to preferentially interact
with the negatively charged surfaces of bacteria in favor of the more
neutral surfaces of eukaryotic cells. However, the detailed mecha-
nism(s) by which AMPs disrupt bacterial membranes and kill cells
are not well understood [3,4].
Standard bulk culture measurements of AMP activity include the
minimum inhibitory concentration assay (MIC) and the minimum
bactericidal concentration assay (MBC) [5]. The MIC is the concen-
tration above which cell growth is not observed over a speciﬁed num-
ber of hours (usually 6 to 24 h) in the continuing presence of AMP.
The (typically larger) MBC is the concentration at which cells re-
moved from the AMP-containing medium do not produce new colo-
nies on fresh agar plates lacking the AMP. It is often observed thatreen ﬂuorescent protein; MIC,
bactericidal concentration;
haar@chem.wisc.edu
rights reserved.L- and D-optical isomers of the same antimicrobial peptide have
very similar MIC values. This strongly suggests that the growth-
halting mechanism is primarily biophysical, rather than some speciﬁc
mode of binding to a particular protein [6]. There are exceptions to
this observation, as some AMPs have been shown to inhibit pepti-
doglycan synthesis [7]. Many of the proline rich AMPs have been
shown to have a non-membrane permeabilizing mechanism of ac-
tion, and do not exhibit similar MIC values for optical isomers of the
peptide [6]. Real time RT-PCR performed on Bacillus subtilis exposed
to the AMPs LL-37 and PG-1 have suggested that AMPs cause signiﬁ-
cant changes in gene expression by triggering stress-related signaling
pathways [8].
Experiments that study AMP interactions with model lipid bilayer
systems have provided important structural characterization by
NMR, oriented circular dichroism, and X-ray and neutron scattering.
Different mechanisms of membrane disruption have been proposed,
including localized pore formation [9], global lipid segregation [10],
and carpet- or detergent-like micellization [11]. For the human anti-
microbial peptide LL-37 of interest here, there has been debate about
its mechanism of membrane disruption. Some work supports a carpet
model for membrane disruption [12,13], while other work supports
the pore mechanism [14,15]. In a complementary method, molecular
dynamics simulations using an atomistic model of melittin in a lipid
bilayer strongly suggest that localized AMP-induced membrane dis-
ruptions have ill-deﬁned structures only vaguely reminiscent of
well-deﬁned barrel-stave or toroidal pores [16]. Similar results were
found for the shape of the pores formed by magainin [17]. The rele-
vance of studies of model lipid bilayers to real bacterial membranes
remains an open question.
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copy techniques that provide a newwindowon AMP interactionswith
live bacterial cells. A combination of imaging methods monitors cell
length andmembrane permeabilization events over time in each indi-
vidual cell. Our initial study [18] of the attack of the α-helical AMP
LL-37 and a rhodamine-labeled derivative (Rh-LL-37) on the Gram-
negative E. coli showed that cell growth halted when Rh-LL-37
translocated across the outer membrane to gain access to the peri-
plasm. This occurred long before permeabilization of the cytoplasmic
membrane. On translocation Rh-LL-37 binds to immobile elements
within the periplasm. We suggested that the growth-halting mecha-
nism was interference with peptidoglycan synthesis.
Here we present a detailed study of the effects of LL-37 on the
model Gram-positive bacterium B. subtilis. Our data suggests two dif-
ferent mechanisms of growth inhibition depending on the bulk LL-37
concentration. At 2 μM LL-37 (twice the 6-hr MIC), the cell growth
rate decreases without permeabilization of the membrane to the
small dye Sytox Green. At 4 μM LL-37, cells abruptly shrink and
Sytox Green gains entry to the cytoplasm, indicating loss of turgor
pressure and presumably loss of the transmembrane potential. In a
novel “recovery assay”, we remove the LL-37 after a ﬁxed interaction
time and monitor for recovery of normal growth over several hours.
The growth-slowing symptom at 2 μM LL-37 is reversible for at least
some cells, while the abrupt permeabilization symptom at 4 μM is not.2. Materials and methods
2.1. Chemicals
Solid LL-37 was purchased from Anaspec (95% pure, Catalog no.
61302, Fremont, CA) and used without further puriﬁcation. A 1 mM
stock solution of LL-37wasmade from 1 mg LL-37 and sterile, ultrapure
(18 MΩ) water. This solution was separated into 50 μL aliquots, and
stored at -20 °C until needed. LL-37 composed of all D-amino acids
(D-LL-37) at 92% purity was made by the University of Wisconsin-
Madison Biotech center and stored the same way. A 5 mM Sytox
Green solution inDMSOwas purchased fromMolecular Probes (Catalog
no. S7020, Grand Island, NY). The sodium salt of nigericin was pur-
chased from Sigma Aldrich (Catalog no. N7143, St. Louis, MO) and
dissolved in ethanol. Supplements used for the media (5X EZ supple-
ment Beta, M3104; 10X ACGU Beta, M3103; 10X MOPS mix, M2137)
were purchased from Teknova (Hollister, CA).2.2. Strains and growth conditions
B. subtilis 168 from the Bacillus Genetic Stock Center (BGSC, code
1A1) was used as the wild type strain. Plasmid pAD43-25 [19], also
from BGSC, produces GFPmut3 under the control of a constitutive pro-
moter. Our B. subtilis strain was made competent and then trans-
formed with pAD43-25 based on the two-step method found in
Molecular Biological Methods for Bacillus [20]. The strain with
pAD43-25 was grown and imaged with 5 μg/mL chloroamphenicol
to select for the plasmid. All strains were grown in a rich deﬁned
medium that we name s-EZRDM (“subtilis-EZRDM”), at 37 °C and
200 rpm (0.9 g) in a New Brunswick Excella E24 Incubator-Shaker.
The recipe is given in the Supplemental Information (Tables S1-S4).
This medium offers the beneﬁt of a doubling time similar to that of
B. subtilis in Luria-Bertani broth (20 min at 37 °C), but with low back-
ground ﬂuorescence. Cultures were grown in s-EZRDM overnight, in-
oculated from a frozen glycerol culture. The following day, dilutions
of at least 1/200 were made into pre-warmed s-EZRDM. Cells were
grown to an OD of 0.04–0.06 (600 nm, 1 mm path length) as mea-
sured on a Nanodrop 2000 from Thermo Scientiﬁc, and then harvested
for microscopy or MIC measurements.2.3. Minimum inhibitory concentration (MIC) assay
MICs were measured only on wild type B. subtilis. A serial dilution
of either LL-37 or D-LL-37 was performed in one row of a polystyrene
96-well plate in s-EZRDM, beginning at 32 μM and with twofold dilu-
tion at each step. The ﬁnal volume in each well in the row was 50 μL
after serial dilution. A liquid cell culture was grown in the same con-
ditions as described in Section 2.2, to a ﬁnal OD of 0.04–0.06. This cul-
ture was diluted in s-EZRDM to an OD of 0.005. 50 μL of the diluted
culture was added to each well of the LL-37 serial dilution, so that
the maximum concentration tested was 16 μM. The ﬁnal OD in each
well was 0.0025, and the ﬁnal volume in each well was 100 μL. A sec-
ond row contained 50 μL of s-EZRDM plus 50 μL of inoculum (positive
growth control), while a third row contained 100 μL of s-EZRDM in
each well (negative growth control and blank for OD measurements).
The plate was incubated at 37 °C while shaking at 200 rpm (0.9 g) in
an Excella 24 Incubator/Shaker from New Brunswick Scientiﬁc for up
to 12 h. The “6-hr MIC” is reported as the lowest concentration for
which no cell growth could be detected after 6 h, as determined by
measurements of OD at 595 nm using a Wallac EnVision 2100
Multilabel Reader from Perkin–Elmer. TheMIC experiments were per-
formed three times, and were reproducible to within a dilution factor
of two. D-LL-37 and LL-37 had the same 6-h MIC of 1 μM.
2.4. Microscopy experiments
All microscopy experiments were carried out at 37 °C. The home
built, temperature-controlled ﬂow chamber, with an internal volume
of ~60 μL, was described previously [18]. The only modiﬁcation was
coverslip preparation. We initially tried poly-L-lysine coated slides
to immobilize cells for observation, but found that B. subtilis had dif-
ﬁculty growing on this surface. Instead, coverslips were sonicated
for 30 min in acetone, rinsed with ultrapure water, and dried with ni-
trogen gas. Cells harvested from the mid-log phase liquid culture
were diluted 1/6 in pre-warmed s-EZRDM, then injected into the
ﬂow chamber. The cells were rinsed with at least 0.8 mL of fresh me-
dium to remove unadhered cells. The 0.5 mL antimicrobial solution,
also made with s-EZRDM, contained both LL-37 and 0.5–1 nM Sytox
Green, unless otherwise stated. This solution was vortexed for at
least 10 s to break up possible aggregates of LL-37. Time-lapse imag-
ing began when a region with a suitable density of plated cells was
found. LL-37/Sytox Green was injected 7.5 min after the beginning
of the movie; the injection itself required ~20 s. The growth medium
was subsequently static after injection.
Time-lapse, wideﬁeld imaging of a ﬁeld of single cells monitored
entry of Sytox Green into the cytoplasm by the onset of its green ﬂuo-
rescence, as well as cell length and width vs time by phase contrast
imaging. In some experiments, Sytox Greenwas omitted and cytoplas-
mic GFP was imaged in the green channel. The Nikon Eclipse TE300
microscope was equipped with a Nikon Phase Contrast Type DLL Ob-
jective, NA = 1.3 and an Andor iXon 897 EMCCD camera. All ﬂuores-
cence images were taken using 488 nm excitation light from an Ar+
laser at an intensity of 6.6 W/cm2 at the focal plane where the cells
are imaged. A 500 nm long-pass ﬁlter (HQ500LP, Chroma Technology)
was used in the microscope dichroic cube. Emission ﬁlters (also from
Chroma) were HQ510/20 M for Sytox Green, and ET525/50 M for cy-
toplasmic GFP. Phase contrast images were collected with the same
emission ﬁlter used to image the corresponding ﬂuorescence channel.
Most time lapse movies were obtained as follows. A 50-ms ﬂuores-
cence image was taken, followed 6 s later by a 50-ms phase contrast
image. This 12-s imaging cycle was repeated 300 times to obtain a 1 h
movie. A few of the growth control movies used an 18 s cycle time.
Faster movies focusing on the staining dynamics of Sytox Green (but
still including alternate phase contrast images) were obtained with a
2-s cycle time. The fastest movies with a 0.5-s cycle time imaged only
the green ﬂuorescence.
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and contains a rich medium, but the experiments presented here
were performed under static conditions. We are unable to ﬂow
LL-37 continuously due to the large volume of injection solution need-
ed and the cost of the peptide. The B. subtilis cells in the chamber are
presumably growing anaerobically duringmost of the observation pe-
riod, since oxygen is not continuously replenished. B. subtilis can grow
anaerobically through fermentation if both glucose and all 20 amino
acids are provided [21], as in our growth medium. The doubling time
of the cells in the static ﬂow chamber is approximately 60 min, three
times longer than the 20-min doubling time in aerated liquid culture.
When B. subtilis cells are grown in the chamberwith a continuous ﬂow
of aerated medium, the doubling timematches the liquid culture dou-
bling time, suggesting that interaction with the glass surface does not
impede growth.
2.5. Data analysis
Movies from time-lapse imaging were analyzed using imageJ [22],
and the programmicrobeTracker [23] using algorithm 4 with modiﬁca-
tions to the following parameters: areaMin = 300, thresFactorM = 1.2,
thresFactorF = 1.2, splitThreshold = 0.5, joindist = 8, joinangle =
1.2. MicrobeTracker calculates cell length and volume for each cell at
all frames. Cell widthwwas calculated as the average of the widthmea-
surements obtained from the MicrobeTracker meshes over the central
60% of the cell length L. This ensured the endcaps were excluded from
the width measurements. Width measurements were also performed
using ImageJ on ﬂuorescence images of GFP in the strain of B. subtilis
producing cytoplasmic GFP. Thewidth estimates from the twomethods
were consistent with one another. The values of cell length, width,
and volume calculated from MicrobeTracker were compared to a
spherocylinder model to conﬁrm that the program was returning rea-
sonable data (Fig. S1 and Table S5). Relative cell length vs time was cal-
culated as Ltotal/L0, where Ltotal is the sum of the tip-to-tip lengths of the
original cell plus any daughter cells it created and L0 is the length of the
cell at the beginning of the movie. Relative changes in cellular dimen-
sions as calculated by MicrobeTracker are quite reliable, while the ab-
solute values depend somewhat on parameters chosen within the
program.
3. Results
3.1. Effects of LL-37 on growth of individual cells
We have studied the effects of LL-37 on the growth of single
B. subtilis cells in the concentration range 0 to 4 μM (up to four times
the 6-h MIC of 1 μM). A total of 62 cells were analyzed (0 μM LL-37,
N = 9; 1 μM, N = 15; 2 μM, N = 21; 4 μM, N = 17). LL-37 and
D-LL-37 yielded similar results. Fig. 1 shows the typical effects of
LL-37 on the growth of individual cells. A representative example
from a “growth control” experiment (mediumwith no LL-37 injected)
is shown in Fig. 1A–C. This particular cell forms an obvious septum
at t ~ 30 min and eventually divides. Sytox Green staining does
not occur, as shown by the absence of Sytox Green ﬂuorescence
(Fig. 1B). Cell length and cell volume, as measured byMicrobeTracker,
are presented in Fig. 1C. The red lines represent exponential ﬁts to the
data, using the exponential growth function Y(t) = Y0 exp[(t − t0) / τ],
where Y represents either cell length (L) or volume (V). Here t0 is the
time at which observation begins and Y0 is the length or volume of
the cell at t0. The only ﬁtting parameter is the base-e time constant τ.
The time constant τ is related to the more typically reported doubling
time td as: td = τ ln2 = 0.693 τ. For this particular cell, a good ﬁt is
obtained with the value τ = 77 min (td = 54 min) for cell length,
and τ = 68 min (td = 47 min) for cell volume. Volume is not propor-
tional to length due to endcap effects.An example of the effects of 2 μM LL-37 (twice the 6-h MIC) on
B. subtilis growth in the ﬂow chamber is shown in Fig. 1D–F, and in
Supplementary Movie 1. Prior to injection and for a lag time of
~5 min after injection, the length increases vs time with a slope rem-
iniscent of unperturbed growth. At t ~ 5 min after injection the curva-
ture turns negative rather abruptly while the length continues to
increase, i.e., the growth rate decreases. The cell continues to lengthen,
albeit more and more slowly, over the entire 50 min of observation
after injection. The cell evidently maintains much of its biopolymer
content throughout, as evidenced by the absence of apparent changes
in phase contrast between the cytoplasm and the surrounding medi-
um. As shown in the green ﬂuorescence images (Fig. 1D) and the inte-
grated Sytox Green intensity plot vs time (Fig. 1E), the cell nucleoid is
not stained with Sytox Green, a cell-impermeant nucleic acid stain
with a higher afﬁnity for DNA than RNA [24]. Cells should exhibit nu-
cleoid staining only if the barrier function of the plasma membrane
has been compromised to Sytox Green. Evidently, cell growth rate is
attenuated by 2 μM LL-37, but the barrier function of the membrane
is maintained, at least to Sytox Green. The estimated radius of Sytox
Green is ~1 nm [25], assuming a spherical molecule. Cell volume and
cell length vs time (Fig. 1F) exhibit similar curves, indicating that
real growth (increasing volume) is occurring.
The observations are very different at 4 μM LL-37 (four times the
6-h MIC), as shown in Fig. 1G–I and Supplementary Movie 2. At t =
3.5 min after injection of LL-37, the cell length shrinks abruptly by
16%, while the width shrinks by 7% (Fig. 1G and H). The change in
cell width is calculated for the frames immediately before and after
shrinkage. This abrupt shrinkage typically occurs in less than one
imaging cycle (b12 s). Within 10–20 s of the cell shrinkage event,
the Sytox Green ﬂuorescence signal begins a sharp rise, direct evi-
dence of membrane permeabilization (Fig. 1H). The cytoplasm still
maintains its overall biopolymer density as judged by phase contrast
images, which indicates that most cytoplasmic components remain
within the cell wall. We interpret the abrupt shrinkage as arising
from membrane permeabilization and loss of turgor pressure, as
discussed in detail below.
A surprising behavior at 4 μM LL-37 is the gradual increase in cell
length immediately after the shrinkage event, as shown in Fig. 1I.
While the cell never achieves its pre-shrink length over the 50-min
observation time, the increase in length could mean that cell growth
has been reestablished, albeit at a slower rate than before introduction
of LL-37. However, the volumemeasurements (Fig. 1I) showno appre-
ciable change in cell volume after cell shrinkage, indicating no real cell
growth.While cell length is increasing, the cell width is decreasing in a
way that preserves volume. Values of cell length, width, and volume
before and after shrinkage can be found in Table S6, and conﬁrm our
hypothesis about cell volume preservation.
In order to test whether or not the membrane remains permeable
after the shrinkage event, we performed experiments in which 4 μM
LL-37 in growth medium without Sytox Green was injected at t = 0,
and Sytox Green in growth medium was injected at varying delay
times after all of the cells in the ﬁeld of view had shrunk. Without
Sytox Green, cell length again slowly recovered after abrupt shrinkage,
indicating that Sytox Green was not causing the slow length recovery.
When 1 nM Sytox Green was injected either ~5 min or ~40 min after
the last cell in the ﬁeld of view had shrunk (t = 10 min or 45 min, re-
spectively), visible staining of the nucleoid again occurred within
~20 s of Sytox Green injection. These experiments demonstrate that
the loss of membrane integrity is irreversible on the 50-min time
scale, i.e., the membrane does not re-establish its barrier function to
molecules the size of Sytox Green.
We also measured several length vs time curves at 8 μM LL-37
without Sytox Green (Fig. S1). Abrupt shrinkage events occur earlier
at this higher concentration (within ~1 min for 8 μMLL-37, compared
to ~3 min for 4 μM LL-37). In contrast to the typical behavior at 4 μM
LL-37, there was little or no recovery of length after shrinkage. We
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Fig. 1. Imaging and analysis of one typical cell for LL-37 concentrations of 0 μM (panels A–C), 2 μM (D–F), and 4 μM LL-37 (G–I). Column at left shows phase contrast and green
ﬂuorescence images vs time. Middle column shows cell length (inverted triangles, left axis) and integrated Sytox Green ﬂuorescence intensity (green circles, right axis) vs time.
Column at right shows cell length (inverted triangles, left axis) and cell volume (blue squares, right axis) vs time. The red lines in B and C are exponential ﬁts to the length
data. Scale bar is 2 μm.
1514 K.J. Barns, J.C. Weisshaar / Biochimica et Biophysica Acta 1828 (2013) 1511–1520discuss possible interpretations of the length and volume behavior
below.
3.2. Comparisons among cells
Thus far we have presented data on single cells, to show the level
of information we can acquire from these experiments. In Fig. 2 we
compare length vs time plots for a number of cells observed at
LL-37 concentrations of 0, 1, 2, and 4 μM. Because cells have different
lengths prior to injection, we plot the relative cell length L(t)/L0,
where L0 is the length at the beginning of the movie (t0, prior to injec-
tion). If all cells grew exponentially at the same rate, then all of the
L(t)/L0 plots would superimpose.
As estimated from length, the growth control curves (0 μM LL-37,
Fig. 2A) have a mean value of the base-e growth time constant of
b τ > = 85 ± 10 min (±one standard deviation), corresponding to
amean doubling time of b td > = 59 ± 6 min. Themodest dispersion
may be due to natural variations among cells or to mild heterogene-
ities within the sample cell. As a reference, the mean of all 9 growth
control curves is plotted as a heavy black line in the plots of L(t)/L0
for non-zero LL-37 concentrations.
At 1 μM LL-37 (equal to the 6-hMIC value, Fig. 2B), some cells con-
tinue to grow normally throughout the 50-min observation periodwhile approximately one-third of the cells show mild growth rate
attenuation. The signature of growth rate attenuation is the change
in curvature of L(t)/L0 from positive to negative. Sytox Green never
stains the nucleoid at 1 μM LL-37. At 2 μM LL-37 (Fig. 2C), ~70% of
cells exhibit growth rate attenuation without Sytox Green staining.
The growth rate attenuation is more severe than at 1 μM LL-37.
About 30% of the cells exhibit abrupt shrinkage and subsequent
Sytox Green staining. At 4 μM LL-37 (Fig. 2D), all of the cells exhibit
shrinkage and Sytox Green staining. The mean lag time between
LL-37 injection and shrinkage is 3.5 ± 1.2 min. After shrinkage, most
cells exhibit a modest recovery of cell length over 50 min. At 8 μM
LL-37 (Fig. S2), all cells shrink abruptly with a mean time to shrinkage
of 0.8 ± 0.2 min. There is little or no evidence of gradual recovery of
length after shrinkage at 8 μM LL-37.
In Fig. 2, the experiment was repeated at least 3 times for each of
the four different concentrations. All the data are combined. The vari-
ability in Fig. 2B–D is primarily due to variation between individual
experimental runs, rather than cellular heterogeneity within a single
experiment. Fig. S3 shows this in greater detail. The cause of the ex-
perimental variability may be our inability to prepare uniformly active
LL-37 samples, variable loss of peptide to the surfaces of the sample
chamber, or inherent day-to-day variability in growing of B. subtilis
cultures.
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Fig. 3. Sytox Green images vs time after abrupt shrinkage events using 4 μM LL-37. Im-
ages were acquired every 2 s, but only every third frame is shown in the sequence of
images (6-s spacing). (A) An example of localized staining that begins at a single
pole, and subsequently spreads to the rest of the nucleoid. The scale bar of 2 μm also
applies to the images in B and C. (B) Example of localized staining beginning at both
poles. (C) Example of a more global staining pattern when Sytox Green is added
45 min after introduction of LL-37, long after the shrinkage event. Staining begins si-
multaneously at all four nucleoid lobes and is not localized.
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As visualized by Sytox Green ﬂuorescence at long times, most cells
under these growth conditions exhibit two major nucleoid lobes
(Fig. 1G). For longer cells, each lobe shows evidence of partial segre-
gation into two sub-lobes. The fast movies of Fig. 3 demonstrates that
at 4 μM LL-37, the initial entry of Sytox Green into the cytoplasm is lo-
calized. Using 2 s/frame time resolution, ~50% of the cells show initial
staining in a single punctum, followed by a gradual spreading of in-
tensity to the rest of the nucleoid. The other half of the cells exhibit
two or more puncta, and only one or two cells in the group of 28 ob-
served cells showed apparent “global” staining (staining without ini-
tial spatial localization.) In the example of Fig. 3A and Supplementary
Movie 3, staining begins at the endcap of the cell and spreads to
completely stain all nucleoid lobes in 1.6 min. This is an example of
initial staining at one punctum. In the example of Fig. 3B, staining be-
gins at both endcaps almost simultaneously, and then moves towards
the middle of the cell to completely stain all nucleoid lobes.
As an additional experiment, we injected Sytox Green ~45 min after
introduction of LL-37, well after cell shrinkage (Fig. 3C). At these long
time delays, Sytox Green staining was rapid, but was more global than
punctal. Themore global staining patternmight be due to global disrup-
tion of membrane function to molecules the size of Sytox Green. It may
also be due to one local, highly permeable patch that admits Sytox
Green so rapidly that we do not catch the localized staining in time.
The initially punctal staining pattern ﬁts a model in which Sytox
Green enters the cytoplasm through a small membrane patch, binds
locally to DNA, gradually saturates the local binding sites, and then
spreads outward in space to ﬁnd additional binding sites until the en-
tire nucleoid lobe is saturated. In such a model, the time scale on
which the staining coats the entire nucleoid lobe depends on many
factors, including the Sytox Green bulk concentration, the permeabil-
ity of the small patch, and the binding/diffusion kinetics of Sytox
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observed ~1 min time scale for complete staining.
In the earliest image showing clear Sytox Green staining, the puncta
are typically round but not diffraction limited. Even at 2 s/frame, the ini-
tial full width at half-maximum (FWHM) intensity is typically about
500 nm. Because the FWHM of the point-spread function is ~250 nm,
we estimate an upper limit on the breadth of the source of the ﬂuores-
cence as ~400 nm. Because the Sytox Green will spread out in space
after entry into the cytoplasm, the small size of the initial staining
patch sets an upper bound on the size of the initially permeabilized
membrane patch. Localized staining implies localized membrane per-
meabilization, but diffraction-limited ﬂuorescence microscopy cannot
determine whether the initially permeabilized membrane patch is a
pore or a disordered local disruption of the membrane. We can only
say that the small size of the initial Sytox Green/DNA patch is consistent
with pore formation.
3.4. Gradual permeabilization to larger species at long times by LL-37
at 4 μM
We carried out several experiments using 4 μM LL-37 on cells ex-
pressing GFP in the cytoplasm. To avoid interference in the green
channel, no Sytox Green was added. A ﬂuorescence intensity vs time
trace for a single cell is shown in Fig. 4. In all cells observed (N = 9)
with 12-s cycle time between frames, the GFP ﬂuorescence intensity
ﬁrst decreased by ~20–30% in one camera frame, coincident in time
with the instant of cell shrinkage, and then abruptly leveled off. As ar-
gued below, we believe the abrupt decrease in intensity at the time of
shrinkage is a photophysical effect, i.e., that it is not due to loss of GFP
from the cytoplasm. At much longer times, t ~ 15–50 min after injec-
tion, the remaining GFP signal was lost. This loss occurs gradually over
5 to 10 min; the trace shows rounded edges at the beginning and end.
We attribute this second loss of GFP ﬂuorescence to delayed perme-
abilization of the membrane to GFP. It should be noted that for mole-
cules the size of GFP, it is possible that the peptidoglycan layermay act
as a permeability barrier along with the membrane.
The 20–30% loss of GFP intensity at the time of shrinkage occurred
in a single camera frame even when the frame time was as short as
0.5 s (Fig. S4). If this were due to loss of GFP, it would require much
of the GFP to ﬁnd the localized permeabilization patch in b0.5 s.
While we have found no measurements of the diffusion constant of
GFP inside the cytoplasm of B. subtilis in the literature, the diffusion
constant of GFP in E. coli has been found to range from ~4 to 14 μm2/s
[26,27]. Even at 14 μm2/s, it would not be possible for the GFP to diffuse
through the localized permeabilization patch in less than half a second.
The argument is presented in detail in the Supplemental Information.
Instead, we believe that the abrupt decrease in cytoplasmic pH during
the shrinkage event causes a decrease in GFP quantum yield. Our medi-
um is buffered at pH 7.4, which leads to an internal pH of ~7.8–8.1
[28,29].When themembrane is permeabilized, the pH in the cytoplasm
will abruptly decrease by ~0.5 pH units to the pH of the buffered medi-
um. The particular GFP used here, GFPmut3, is known to be sensitive to
pHwith decreasing ﬂuorescence intensity as pHdecreases, the samedi-
rection as our observations [30]. As an additional test, we carried out
experiments injecting the drug nigericin, which eliminates the ΔpH
across the membrane by exchanging K+ for H+ across the membrane
[31,32]. As shown in Fig. S5, 5 μM nigericin leads to an approximately
30% decrease in GFP signal for the cell shown; all cells analyzed showed
a 25–35% loss of GFP signal. For nigericin treatment, there is never com-
plete loss of GFP at longer times after shrinkage (up to 1 h). Separate ex-
periments conﬁrmed that after nigericin treatment, Sytox Green did not
enter the cytoplasm up to 52.5 min after injection.
In one experiment, cells not expressing GFP were incubated
in 4 μM LL-37 without Sytox Green and observed for longer periods
of 2-3 h. Cells abruptly shrank at t ~ 2–4 min as usual. For the two
cells shown in Fig. 5 and Supplementary Movie 4, beginning att ~ 80 min, we observed yet another behavior in which the shrunken
cells lost phase contrast over a period of ~70 min. The time at which
loss of phase contrast begins and the length of time over which it is
lost is highly variable across cells and individual experimental runs.
Similar results were obtained with cells producing cytoplasmic GFP.
To summarize, 4 μM of LL-37 gradually causes permeabilization of
themembrane to larger and larger species over a period of hours. Simul-
taneous with the shrinkage event, Sytox Green permeates the mem-
brane locally; the pH presumably equilibrates across the membrane at
the same time. The membrane is permeabilized to proteins the size of
GFP only much later, ~10–50 min after LL-37 addition. Localized Sytox
Green staining is not observed when Sytox Green is injected ~45 min
after LL-37 introduction (presumably when cytoplasmic GFP has al-
ready been lost). Still later, at t ~ 90 min, even ribosomes permeate
the membrane. It is important to note that at some point during the
gradual increase in permeabilization, the peptidoglycan layer will also
act as a permeability barrier. In order for large, 20-nm diameter species
[33] like ribosomes to escape from the peptidoglycan layer, the natural
mesh size of the layer must expand [34]. We suspect that the driving
force for this breakdown in the peptidoglycan layer is autolysis
[35,36], as further explored in the discussion section.
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For all data reported thus far, B. subtilis cells are incubated in LL-37
throughout the entire observation period, as would occur in an MIC
assay. In the following “recovery” experiments, cells in the ﬂow cham-
ber are incubated at a given LL-37 concentration for a period of time,
and then rinsed with fresh, aerated growth medium. Sytox Green
is not present. Observation by phase contrast continues for 2-3 h,
depending on the time scale of symptoms. This is analogous to a
single-cell minimum bactericidal concentration (MBC) assay. The
goal is to determine the extent to which cells whose growth has
been altered by LL-37 can recover and grow normally after restoration
of aerated s-EZRDM growth medium.
In Fig. 6A,we show a cell incubated in 2 μMLL-37 beginning at t = 0
and then rinsed thoroughly at t = 33 min and again at t = 58 min.
The rinses cause defocusing of the phase contrast image and small
jogs in the L(t) curve. As described in Section 3.1, LL-37 changes the cur-
vature of L(t) (attenuates the growth rate) but does not entirely halt
growth. Within ~20 min of rinsing with fresh growth medium, L(t)
again turns upward for the cell shown in Fig 6A. As judged by the
base-e time constant τ = 113 min, the cell has reestablished growth,
albeit at a slower growth rate than if LL-37 had never been present.
There is heterogeneity across cells in the recovery behavior at 2 μM
LL-37. Some cells resume normal growth, as in Fig. 6A. Some cellsabruptly shrink at longer time scales even though external LL-37 has
been removed. Still other cells never resume growth during the obser-
vation period of 2–3 h. Evidently an entire culture whose growth rate
was attenuated by exposure to 2 μM LL-37 for ~30 min would readily
recover after restoration of normal growth medium.
In contrast, Fig. 6B shows the recovery behavior of a cell initially
incubated in 4 μM LL-37. In this experiment, all the observed cells suf-
fered abrupt shrinkage events within 4 min of exposure to LL-37. The
cells were rinsed with fresh, aerated growth medium at t = 6 min
and again at t = 13 min. As occurred without rinsing (Fig. 5), the typ-
ical rinsed cell (Fig. 6B) gradually lengthens after the shrinkage event,
but never regains its pre-shrink length. The volume curve, although
noisy, shows no clear evidence of real growth. Following the rinses,
and beginning at about 60 min, this particular cell gradually loses
phase contrast, suggesting substantial loss of biopolymer content. Of
the 12 cells studied by the recovery method at 4 μM LL-37, all but
one lost phase contrast before reaching the pre-shrink maximum
length. This is essentially the same behavior observed without rins-
ing. None of the observed cells had resumed normal growth by the
end of the observation period of 2–3 h. Evidently the damage inﬂicted
on the cell by exposure to 4 μM for only 6 min is permanent and irre-
versible, in contrast to that imposed by 2 μM for 30 min.4. Discussion
4.1. Comparison of LL-37 attack on E. coli and B. subtilis
The single-cell, real time assay reveals new layers of detail in the
modes of attack of antimicrobial peptides on live bacterial cells. In ear-
lier work, we studied the attack of LL-37 on the Gram-negative species
E. coli. Rhodamine-labeled LL-37 (Rh-LL-37) at 8 μM (4 times the 12-h
MIC of 2 μM) uniformly coats the cell outer membrane in less than
1 min. Cells that were already septating at t = 0 were subsequently
attacked earlier than non-septating cells. After a lag time of about
10 min, Rh-LL-37 translocates across the outer membrane to enter
the periplasm primarily at the septal region, which is evidently
muchmore susceptible to translocation thanmature outer membrane
regions. Growth halts immediately thereafter, just before periplasmic
GFP leaves the cell and long before permeabilization of the cytoplas-
mic membrane to Sytox Green. Below a threshold bulk Rh-LL-37 con-
centration of 4 μM (twice the MIC), the outer membrane was coated
but growth did not halt.We speculated that the growth-haltingmech-
anism involved interference with cell wall synthesis within the peri-
plasm, perhaps due to binding of the highly cationic LL-37 to anionic
components of the nascent peptidoglycan layer. Non-septating cells
appeared to continue to grow until septum formation, at which time
LL-37 penetrated the outer membrane and growth halted.
Here we extend the work to the Gram-positive species B. subtilis,
which has only one membrane. We ﬁnd no evidence for preferential
attack on septating vs non-septating cells, although we are insensitive
to cell cycle due to phase contrast microscopy's limitations in visual-
izing septa in B. subtilis. For both Rh-LL-37 at 8 μM on E. coli and
unlabeled LL-37 at 4 μM on B. subtilis (four times the MIC in both
cases), we observe a several-minute time lag between injection of
LL-37 and the halting of growth. In E. coli, the lag was dominated by
slow translocation across the outer membrane to reach the periplasm.
Bulk and surface-bound Rh-LL-37 rapidly establish an equilibrium
[37]. At Rh-LL-37 bulk concentrations near the MIC, the surface con-
centration builds up quickly, but translocation and growth halting
does not occur during a 60-min observation time. At 8 μM, the higher
surface concentration led to translocation in septating cells, but only
after a 10-min time lag. This is consistent with a cooperative model
of translocation. It suggests that even when a critical surface concen-
tration of Rh-LL-37 is present, multiple peptide molecules must come
together and insert into the membrane, enabling facile translocation.
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before translocation.
In the B. subtilis studywe have avoided use of Rh-LL-37 becausewe
did not observe the same set of symptoms as those induced by
unlabeled LL-37. Rh-LL-37 did not cause the abrupt shrinkage step,
even at concentrations as high as 24 μM. The abrupt, local membrane
permeabilization step for B. subtilis at 4 μM of unlabeled LL-37 again
exhibits characteristics consistent with a cooperative event [38] hav-
ing a nucleation step as a bottleneck. Below a threshold bulk concen-
tration, the membrane permeabilization step does not occur. At
4 μM and above, abrupt permeabilization always occurs, but only
after a substantial time lag. The time lag might be due to slow adsorp-
tion of LL-37 into the peptidoglycan layer; without labels, we cannot
discern the time scale of equilibration between bulk and surface
LL-37. It may also be limited by slow diffusion of the highly positively
charged LL-37 through the thick, negatively charged layer of mature
peptidoglycan. Slow dissociation of helical bundles of LL-37 in the
peptidoglycan layer may also contribute; these bundles are stable in
salty solution and may also be stable in the hydrophilic environment
of the peptidoglycan layer.
4.2. Growth rate suppression at low LL-37 concentration
At 2 μM of LL-37 on B. subtilis (twice the MIC), the concentration is
evidently too low to induce permeabilization of the membrane. An al-
ternativemechanism is observed (Fig. 1D–F). The growth rate, as mea-
sured by the slope of plots of cell length vs time, begins to decrease
about 5 min after injection of LL-37. Cells growmore and more slowly
over at least 50 min, and Sytox Green never enters the cytoplasm. One
plausible cause of this behavior is direct interference with cell wall
synthesis, analogous to the growth-halting mechanism proposed for
E. coli. LL-37 presumably displaces the dipositive cations Mg2+ and
Ca2+within the peptidoglycan layer. A second possibility is transductionof a stress signal through the membrane [8], triggering a change in the
transcription proﬁle, and a decrease in the cell wall production rate. A
third possibility involves a gradual decrease in the proton motive force
across the bacterial membrane. This would lead to gradually decreasing
intracellular levels of ATP, and a gradual decrease in growth rate. We
tried to observe changes in internal pH at 2 μM LL-37 using the strain
of B. subtilis expressing cytoplasmic GFP. Unfortunately, our assay is in-
effective atmeasuring gradual changes in GFP intensity (and thus, inter-
nal pH), due to the competing effect of photobleaching. The cause of the
gradual slowing of growth remains an open question.4.3. Abrupt shrinkage at high LL-37 concentration
At 4 μM and 8 μM of LL-37, a lag time of a several minutes after in-
jection is followed by abrupt shrinkage of all observed cells. LL-37
permeabilizes themembrane,which enables leakage of smallmolecules
and ions from the cytoplasm to the surrounding medium. Much of the
turgor pressure is lost. Sytox Green at 0.5–1 nM bulk concentration en-
ters the cytoplasm and begins to stain the nucleoid less than 20 s after
the shrinkage event. It takes about 5 min for the Sytox Green staining
to reach its asymptotic value. Presumably a membrane permeable to
Sytox Green is also permeable to protons, indicating that the cell mem-
brane potential is abruptly lost as well. The phase contrast of the cyto-
plasm relative to the surrounding medium shows no obvious change
immediately after shrinkage, indicating that much of the biopolymer
content remains within the cytoplasm.
Cell length shrinks by about 15% on average, while the width
shrinks by about 6%, implying an overall volume decrease of 25%.
The turgor pressure is assumed to drop uniformly across the peptido-
glycan. Thus, the change in aspect ratio on loss of turgor suggests that
the normal turgor pressure stretches the peptidoglycan layer more
easily along the long axis than circumferentially.
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recovery of cell length. This recovery does not occur at 8 μM. In the
E. coli study, we often observed a similar shrinkage and partial recov-
ery of cell length [37]. At least in the case of B. subtilis, the gradual
length recovery is not due to real cell growth. The cell never regains
its pre-shrink length over 50 min of observation. Importantly, cell vol-
ume does not increase during this slow increase in length (Fig. 1I). In
addition, the membrane potential evidently remains zero after the
abrupt permeabilization event, preventing ATP synthesis and also
disrupting many crucial metabolic pathways. The experiments using
delayed addition of Sytox Green after shrinkage of the cells conﬁrm
that the membrane barrier function is not restored during the period
of slow length recovery. The delayed loss of cytoplasmic GFP indicates
that cell wall damage gradually becomes more severe over tens of mi-
nutes. We do not understand the restoring force driving the slow
length recovery. It could be due to gradual remodeling of the peptido-
glycan layer by autolysins, whose activity continues even after the
membrane potential is abolished.
4.4. Pore formation?
The observed localized permeabilization of the membrane revealed
by the initially punctal Sytox Green staining at 4 μM LL-37 is consistent
with the hypothesis of pore formation. Accordingly, recent structural
studies on model lipid bilayers indicate that LL-37 indeed forms pores
[14]. However, our assay provides no detailed information about the
structure of the localized membrane disruption in B. subtilis. We only
know that it is small, atmost about 400 nm in breadth, because the ear-
liest images of DNA staining are roundwith full width at half-maximum
intensity of ~500 nm. Different studies suggested that LL-37 permeates
modelmembranes by a “carpet” or “detergent-like”mechanism [12,13].
The observed localized permeabilization events argue against this
mechanism in real bacterial membranes.
The delayed loss of cytoplasmic GFP at t ~ 30 min (Fig. 4) and
the even later loss of most cytoplasmic content at t ~ 1.5 h (Figs. 5
and 6B) indicates that LL-37 treatment slowly causes permeabilization
of the membrane to larger and larger biomolecules, including ribo-
somes, over a period of several hours. This occurs both when the
cells remain in contact with LL-37 and when the bulk LL-37 is rinsed
away. The underlying mechanism of this slow membrane disruption
is not clear. After the initial permeabilization event, the size limit on
which cytoplasmic species are lost may be determined by the porosity
of the peptidoglycan layer rather than themembrane itself. One possi-
bility is that autolysins continue to degrade the peptidoglycan layer
long after the onset of permeabilization and the halting of growth.
4.5. Recovery assay
Herewe introduced a rudimentary “single-cell minimal bactericid-
al concentration” (MBC) assay by injecting LL-37, allowing it to act
over a variable period of time, rinsing the plated cells to remove bulk
LL-37, and then observing whether or not cells recover and resume
normal growth. Although 2 μM exceeds the 6-h MIC, the slowing of
growth on a 30-min time scale at this concentration is a “recoverable”
symptom for many cells. When fresh growth medium is restored,
some cells return to normal growth over a period of ~30 min. We sus-
pect that fresh medium is able to remove much of the LL-37 from the
peptidoglycan layer, i.e., that binding to the cell wall is reversible. Be-
cause the symptoms observed in our 1-h observation period are re-
versible, the data do not reveal the mechanism by which 2 μM LL-37
halts growth over 6 h in the MIC assay.
The recovery experiments at 4 μM rinsed away bulk LL-37 just mi-
nutes after the shrinkage events. No cells were observed to recover
and grow normally on a time scale of 2-3 hr. It seems clear that the
abrupt permeabilization event is sufﬁcient to kill cells. The reason that
permeabilization is not a recoverable symptom is less clear. Possibilitiesinclude irreversible loss of critical cytoplasmic components, irreparable
damage to the cell wall by the action of autolysins, disruption of the
membrane potential, or a combination of all of these effects.
Finally, we comment on the relationship between our 1-h, single-
cell antimicrobial action assay and the time-honoredminimum inhib-
itory concentration assay (MIC). TheMIC is measured as theminimum
antimicrobial concentration that inhibits growth over an extended
time period, typically chosen as 6-12 h. For LL-37 on B. subtilis in
EZRDMgrowthmedium at 37 °C, ourmeasured 6-hMIC is 1 μM, accu-
rate within a factor of two. On the time scale convenient for these mi-
croscopy experiments, about 1 h, we observe only minor effects of
1 μM LL-37 on cell growth (Fig. 3). Our studies focused on the concen-
tration range 2-8 μM, well above the 6-h MIC, because these concen-
trations yield measureable effects on a 1-h time scale. The effects
observed on the 1-h time scale are very different at 1 μM, 2 μM, and
4–8 μM. This suggests that for concentrations above theMIC, the dom-
inant microscopic mechanism of anti-bacterial action may vary sub-
stantially with increasing antimicrobial concentration. However, we
cannot be certain that the microscope sample chamber maintains
the initial bulk LL-37 concentration over long periods. It remains pos-
sible that the growth rate suppression observed at 1–2 μM is the real
behavior at constant bulk concentrations just below the MIC and
that the abrupt shrinkage observed at 4–8 μM is the real behavior at
constant bulk concentrations just above the MIC. In future work,
recovery assays withmuch longer exposure times to LL-37 will be car-
ried out in a microﬂuidic ﬂow chamber to ensure constant bulk pep-
tide concentration.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.02.011.References
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